M2Gen: Helge Bastian

Health informatics firm M2Gen recently appointed Helge Bastian as president and CEO. Bastian succeeds William Dalton, executive chair of the firm and interim CEO since September 2018. Bastian joins M2Gen from Thermo Fisher Scientific, where he led the sample preparation and synthetic biology businesses as vice president and general manager since 2014. Before that, he held a number of senior leadership positions and served as a member of several executive leadership teams, including managing director and chief commercial officer at Indivumed; vice president of global marketing, business development, and strategy at Sigma-Aldrich (now Merck KGaA); executive vice president of life science services for SGS; and various management positions at Qiagen including vice president of molecular diagnostics, VP of global strategic marketing, and VP of PreAnalytiX, a Qiagen/Becton Dickinson joint venture.